These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10762507)

  • 1. Use of "unidentified bright objects" on MRI for diagnosis of neurofibromatosis 1 in children.
    DeBella K; Poskitt K; Szudek J; Friedman JM
    Neurology; 2000 Apr; 54(8):1646-51. PubMed ID: 10762507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unidentified bright objects on brain MRI in children as a diagnostic criterion for neurofibromatosis type 1.
    Lopes Ferraz Filho JR; Munis MP; Soares Souza A; Sanches RA; Goloni-Bertollo EM; Pavarino-Bertelli EC
    Pediatr Radiol; 2008 Mar; 38(3):305-10. PubMed ID: 18231788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Globus pallidus high-signal lesions: A predominant MRI finding in children with neurofibromatosis type 1.
    Khan A; Beri S; Baheerathan A; Balki A; Hussain N; Gosalakkal J
    Ann Indian Acad Neurol; 2013 Jan; 16(1):53-6. PubMed ID: 23661963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unidentified bright objects in neurofibromatosis type 1: conventional MRI in the follow-up and correlation of microstructural lesions on diffusion tensor images.
    Ferraz-Filho JR; José da Rocha A; Muniz MP; Souza AS; Goloni-Bertollo EM; Pavarino-Bertelli EC
    Eur J Paediatr Neurol; 2012 Jan; 16(1):42-7. PubMed ID: 22088602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of unidentified bright objects in the neurocognitive profile of neurofibromatosis type 1 children: a volumetric MRI analysis.
    Di Stasi M; Cocozza S; Buccino S; Paolella C; Di Napoli L; D'Amico A; Melis D; Ugga L; Villano G; Ruocco M; Scala I; Brunetti A; Elefante A
    Acta Neurol Belg; 2024 Feb; 124(1):223-230. PubMed ID: 37733157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thalamo-striatal T2-weighted hyperintensities (unidentified bright objects) correlate with cognitive impairments in neurofibromatosis type 1 during childhood.
    Chabernaud C; Sirinelli D; Barbier C; Cottier JP; Sembely C; Giraudeau B; Deseille-Turlotte G; Lorette G; Barthez MA; Castelnau P
    Dev Neuropsychol; 2009; 34(6):736-48. PubMed ID: 20183730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofibromatosis type 1: diffusion weighted imaging findings of brain.
    Alkan A; Sigirci A; Kutlu R; Ozcan H; Erdem G; Aslan M; Ates O; Yakinci C; Egri M
    Eur J Radiol; 2005 Nov; 56(2):229-34. PubMed ID: 15963674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI abnormalities in neurofibromatosis type 1 (NF1): a study of men and mice.
    Rosenbaum T; Engelbrecht V; Krölls W; van Dorsten FA; Hoehn-Berlage M; Lenard HG
    Brain Dev; 1999 Jun; 21(4):268-73. PubMed ID: 10392751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using a semi-automated approach to quantify Unidentified Bright Objects in Neurofibromatosis type 1 and linkages to cognitive and academic outcomes.
    Harriott EM; Nguyen TQ; Landman BA; Barquero LA; Cutting LE
    Magn Reson Imaging; 2023 May; 98():17-25. PubMed ID: 36608909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the detectability of UBOs in Neurofibromatosis Type I patients with proton density-weighted and FLAIR sequences in 3T MRI.
    Tritt S; Hillenbrand N; Liesirova K; Moein G; Kieslich M; Porto L
    Eur J Paediatr Neurol; 2018 Jul; 22(4):615-619. PubMed ID: 29610060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychological profile in Italian children with neurofibromatosis type 1 (NF1) and their relationships with neuroradiological data: Preliminary results.
    Parmeggiani A; Boiani F; Capponi S; Duca M; Angotti M; Pignataro V; Sacrato L; Spinardi L; Vara G; Maltoni L; Cecconi I; Pastore Trossello M; Franzoni E
    Eur J Paediatr Neurol; 2018 Sep; 22(5):822-830. PubMed ID: 29802023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain apparent diffusion coefficient evaluation in pediatric patients with neurofibromatosis type 1.
    Tognini G; Ferrozzi F; Garlaschi G; Piazza P; Patti A; Virdis R; Bertolino C; Bertolino G; Manfredini D; Zompatori M; Crisi G
    J Comput Assist Tomogr; 2005; 29(3):298-304. PubMed ID: 15891494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brainstem tumors in patients with neurofibromatosis type 1: a distinct clinical entity.
    Molloy PT; Bilaniuk LT; Vaughan SN; Needle MN; Liu GT; Zackai EH; Phillips PC
    Neurology; 1995 Oct; 45(10):1897-902. PubMed ID: 7477989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterizing the microstructural basis of "unidentified bright objects" in neurofibromatosis type 1: A combined in vivo multicomponent T2 relaxation and multi-shell diffusion MRI analysis.
    Billiet T; Mädler B; D'Arco F; Peeters R; Deprez S; Plasschaert E; Leemans A; Zhang H; den Bergh BV; Vandenbulcke M; Legius E; Sunaert S; Emsell L
    Neuroimage Clin; 2014; 4():649-58. PubMed ID: 24936416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Unidentified bright objects and neuropsychiatric disturbances].
    Bassi B; Vannelli S; Giraudo MC; Burdino E; Rigardetto R
    Minerva Pediatr; 2013 Aug; 65(4):371-81. PubMed ID: 24051970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion tensor MR imaging in neurofibromatosis type 1: expanding the knowledge of microstructural brain abnormalities.
    Ferraz-Filho JR; da Rocha AJ; Muniz MP; Souza AS; Goloni-Bertollo EM; Pavarino-Bertelli EC
    Pediatr Radiol; 2012 Apr; 42(4):449-54. PubMed ID: 22033857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffuse pontine lesions in children with neurofibromatosis type 1: making a case for unidentified bright objects.
    Hervey-Jumper SL; Singla N; Gebarski SS; Robertson P; Maher CO
    Pediatr Neurosurg; 2013; 49(1):55-9. PubMed ID: 24192157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central nervous system imaging in reevaluation of patients with neurofibromatosis type 1.
    Balestri P; Calistri L; Vivarelli R; Bartalini G; Mancini L; Berardi A; Fois A
    Childs Nerv Syst; 1993 Dec; 9(8):448-51. PubMed ID: 8124670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between T2-weighted hyperintensities (unidentified bright objects) and lower IQs in children with neurofibromatosis-1.
    Denckla MB; Hofman K; Mazzocco MM; Melhem E; Reiss AL; Bryan RN; Harris EL; Lee J; Cox CS; Schuerholz LJ
    Am J Med Genet; 1996 Feb; 67(1):98-102. PubMed ID: 8678124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical sensitivity and specificity of multiple T2-hyperintensities on brain magnetic resonance imaging in diagnosis of neurofibromatosis type 1 in children: diagnostic accuracy study.
    Sabol Z; Resić B; Gjergja Juraski R; Sabol F; Kovac Sizgorić M; Orsolić K; Ozretić D; Sepić-Grahovac D
    Croat Med J; 2011 Aug; 52(4):488-96. PubMed ID: 21853543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.